90 related articles for article (PubMed ID: 2130367)
1. Killer-cell activity in alcohol-originated diseases of the liver, and the effect of alcohol on the K-cell functions under in vitro conditions.
Schnabel R; Bokor M; Malatinszky G; Garam T
Acta Med Hung; 1990; 47(3-4):189-99. PubMed ID: 2130367
[TBL] [Abstract][Full Text] [Related]
2. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption.
Laso FJ; Madruga JI; Girón JA; López A; Ciudad J; San Miguel JF; Alvarez-Mon M; Orfao A
Hepatology; 1997 May; 25(5):1096-100. PubMed ID: 9141423
[TBL] [Abstract][Full Text] [Related]
3. Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake.
Laso FJ; Lapeña P; Madruga JI; San Miguel JF; Orfao A; Iglesias MC; Alvarez-Mon M
Alcohol Clin Exp Res; 1997 Oct; 21(7):1226-31. PubMed ID: 9347083
[TBL] [Abstract][Full Text] [Related]
4. [Spontaneous and interferon-induced activity of natural killer cells in patients with liver cirrhosis and chronic active hepatitis].
Müller C; Zielinski CC
Acta Med Austriaca; 1987; 14(5):115-8. PubMed ID: 3125713
[TBL] [Abstract][Full Text] [Related]
5. [Serum aminoterminal type III procollagen peptide level and killer cell activity in patients with alcoholic liver diseases].
Schnabel R; Jaszovszky S; Bokor M; Garam T
Orv Hetil; 1991 Jul; 132(27):1479-83. PubMed ID: 1956678
[TBL] [Abstract][Full Text] [Related]
6. [Lymphocytotoxicity in alcoholic hepatitis: evalutation of effector cells].
Stefanini GF; Mariani E; Facchini A; Serra S; Miglio F
Boll Soc Ital Biol Sper; 1979 Mar; 55(5):404-10. PubMed ID: 553595
[TBL] [Abstract][Full Text] [Related]
7. [Antibody-dependent cell cytotoxicity and the effect of interferon on K-cell functional activity in vitro in chronic viral hepatitis B in children].
Kaganov BS; Zimin IuI; Uchaĭkin VF; Saidov MZ; Sorokin AM
Biull Eksp Biol Med; 1984 Dec; 98(12):700-2. PubMed ID: 6509200
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of peripheral blood T lymphocytes and natural killer cells in alcoholic hepatitis persist after a 3-month withdrawal period.
Laso FJ; Madruga JI; López A; Ciudad J; Alvarez-Mon M; San Miguel J; Orfao A
Alcohol Clin Exp Res; 1997 Jun; 21(4):672-6. PubMed ID: 9194923
[TBL] [Abstract][Full Text] [Related]
9. Immunology of alcoholic liver disease.
Leevy CB; Elbeshbeshy HA
Clin Liver Dis; 2005 Feb; 9(1):55-66. PubMed ID: 15763229
[TBL] [Abstract][Full Text] [Related]
10. Role of the NK reaction in the diagnostics of liver and pancreas tumours.
Karácsonyi S; Mándi Y; Farkas G; Tóth M; Béládi I
Acta Chir Hung; 1985; 26(1):51-8. PubMed ID: 4002971
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte cytotoxicity in alcoholic hepatitis.
Kakumu S; Leevy CM
Gastroenterology; 1977 Apr; 72(4 Pt 1):594-7. PubMed ID: 65306
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody against liver cell membrane and killer cell activity in chronic liver diseases.
Schnabel R; Dalmi L; Sipka S; Bokor M; Malatinszky G; Garam T
Acta Med Hung; 1991; 48(1-2):23-31. PubMed ID: 1813854
[TBL] [Abstract][Full Text] [Related]
13. Immunologic aspects of alcoholic liver disease.
Zetterman RK; Sorrell MF
Gastroenterology; 1981 Sep; 81(3):616-24. PubMed ID: 6166511
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell activity in alcoholic cirrhosis: influence of nutrition.
Ledesma F; Echevarria S; Casafont F; Lozano JL; Pons-Romero F
Eur J Clin Nutr; 1990 Oct; 44(10):733-40. PubMed ID: 2269252
[TBL] [Abstract][Full Text] [Related]
15. [K-cell activity of peripheral lymphocytes in chronic liver diseases in the light of clinical status and laboratory parameters].
Garam T; Schnabel R; Csepregi I; Marton E; Pakuts B; Salacz A
Orv Hetil; 1987 Nov; 128(44):2307-12. PubMed ID: 3684247
[No Abstract] [Full Text] [Related]
16. Human K cell-mediated haemolysis: determination of the cytotoxic capacity and antibody sensitization requirements of T lymphocyte enriched and depleted populations.
Bakács T; Kimber I; Moore M
J Clin Lab Immunol; 1983 Dec; 12(4):209-15. PubMed ID: 6319706
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
18. The cellular nature of concanavalin A-stimulated antibody-dependent cell-mediated cytotoxicity.
Connolly JM; Wunderlich JR
J Immunol; 1980 Apr; 124(4):1917-23. PubMed ID: 7365243
[TBL] [Abstract][Full Text] [Related]
19. Human K/natural killer cells targeted with hetero-cross-linked antibodies specifically lyse tumor cells in vitro and prevent tumor growth in vivo.
Titus JA; Perez P; Kaubisch A; Garrido MA; Segal DM
J Immunol; 1987 Nov; 139(9):3153-8. PubMed ID: 2959724
[TBL] [Abstract][Full Text] [Related]
20. Non-specific cellular immunity in type I and type II diabetes.
Fövenyi J; Tótpál K; Thaisz E; Garam T
Exp Clin Endocrinol; 1984 Apr; 83(2):203-6. PubMed ID: 6539221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
